📰 Chief Development News
Page 48 - Chief Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chief Development. Real-time updates on events, politics, business and more.
October 17, 2022
/PRNewswire/ -- Integrated Home Care Services, Inc. (IHCS), the nations leading independent administrator of home health, durable medical equipment (DME), and...
October 14, 2022
GoLocal's People on the Move is an update on new hires and promotions across southern New England. If your organization has an announcement, email it to us at news@golocalprov.com.
October 10, 2022
The project supports Saudi’s Vision 2030 goal of hosting 30 million pilgrims by 2030
October 10, 2022
Saudi developer Jabal Omar said work is moving at a steady pace on its mixed-use project in Makkah with Phases 2 and 3 targeted for completion by year-end and Phase 4 in 2024. The three phases comprise 15 towers including 5-star and 4-star luxury hotels.
October 6, 2022
Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace
October 6, 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing small molecule disease-modifying therapeutics that restore and enhance ABC transporter function, continues to grow its senior leadership team. Robert Hughes, Ph.D., recently joined as Executive Vice Presi...
October 5, 2022
Contact: Gillian Gonzalez, CFRE Vice President, Chief Development and Communications Officer Office:(703) 696-7455 / (800) 654-8364 DSN 426-4904 Fax (703) 696-0144.
October 5, 2022
Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that it has closed a Series B financing and named
October 4, 2022
On Monday, Colorado Springs Mayor John Suthers unveiled his proposed 2023 budget for the city. In it, $500,000 has been set aside to support shelter bed operations for the homeless population.
October 4, 2022
04.10.2022 - - Favorable Safety Profiles and Encouraging Efficacy Data Reported in Clinical Trials in the Suprachoroidal Space (SCS) Across Multiple Therapeutic Areas using Clearside’s SCS Microinjector - - SCS Microinjector Featured in Multiple Oral and Poster ... Seite 1